uterine corpus leiomyosarcoma
Showing 1 - 10 of 10
Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Trial in New York
Recruiting
- Locally Advanced Leiomyosarcoma
- +5 more
- Olaparib
- +3 more
-
New York, New YorkColumbia University/Herbert Irving Cancer Center
Jan 4, 2023
Metastatic Leiomyosarcoma, Unresectable Leiomyosarcoma, Uterine Corpus Leiomyosarcoma Trial in Boston (Ipilimumab, Laboratory
Active, not recruiting
- Metastatic Leiomyosarcoma
- +2 more
- Ipilimumab
- +2 more
-
Boston, Massachusetts
- +1 more
Jun 28, 2022
Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Trial in New York
Not yet recruiting
- Locally Advanced Leiomyosarcoma
- +8 more
- Olaparib
- +3 more
- (no location specified)
Jul 6, 2022
Recurrent Uterine Corpus Sarcoma, Stage IIIA Uterine Sarcoma, Stage IIIB Uterine Sarcoma Trial in United States (biological,
Terminated
- Recurrent Uterine Corpus Sarcoma
- +6 more
- Bevacizumab
- +5 more
-
Phoenix, Arizona
- +200 more
Aug 20, 2020
Stage I Uterine Sarcoma AJCC v7, Uterine Corpus Leiomyosarcoma Trial in Worldwide (other, drug, biological)
Terminated
- Stage I Uterine Sarcoma AJCC v7
- Uterine Corpus Leiomyosarcoma
- Clinical Observation
- +5 more
-
Huntsville, Alabama
- +622 more
Apr 20, 2020
Stage IA Uterine Sarcoma, Stage IB Uterine Sarcoma, Stage IC Uterine Sarcoma Trial in Bronx (drug, radiation, other)
Terminated
- Stage IA Uterine Sarcoma
- +10 more
- Gemcitabine Hydrochloride
- +5 more
-
Bronx, New YorkAlbert Einstein College of Medicine
Dec 10, 2019
Recurrent Uterine Corpus Sarcoma, Uterine Corpus Leiomyosarcoma Trial in United States (Ixabepilone, Laboratory Biomarker
Completed
- Recurrent Uterine Corpus Sarcoma
- Uterine Corpus Leiomyosarcoma
- Ixabepilone
- Laboratory Biomarker Analysis
-
Phoenix, Arizona
- +71 more
Aug 6, 2019
Recurrent Uterine Corpus Sarcoma, Uterine Corpus Leiomyosarcoma Trial in Philadelphia (Thalidomide, Laboratory Biomarker
Completed
- Recurrent Uterine Corpus Sarcoma
- Uterine Corpus Leiomyosarcoma
- Thalidomide
- Laboratory Biomarker Analysis
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Jul 22, 2019
Recurrent Uterine Corpus Sarcoma, Uterine Corpus Leiomyosarcoma Trial in Philadelphia (Docetaxel, Filgrastim, Gemcitabine
Completed
- Recurrent Uterine Corpus Sarcoma
- Uterine Corpus Leiomyosarcoma
- Docetaxel
- +3 more
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Dec 7, 2016
Collecting Tumor Samples From Patients With Gynecological Tumors
Completed
- Borderline Ovarian Clear Cell Tumor
- +85 more
- Laboratory Biomarker Analysis
-
Fayetteville, Arkansas
- +186 more
Oct 26, 2016